Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
108 USD | +0.87% | -1.57% | -2.34% |
01:29pm | Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126 | MT |
Apr. 22 | Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.34% | 186B | |
-1.52% | 107B | |
-3.83% | 67.57B | |
+7.88% | 50.7B | |
+15.76% | 47.2B | |
-0.45% | 39.72B | |
+10.46% | 27.48B | |
+2.20% | 25.65B | |
+13.37% | 24.97B | |
-0.35% | 24.82B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Transcript : Abbott Laboratories, Q1 2022 Earnings Call, Apr 20, 2022